Join
Live feed
·
INSIDERFilingvia Quantisnow
Aktis Oncology Inc. logo

SEC Form 4: Boller Kenneth sold $6,930 worth of shares (1,500 units at $4.62) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 91,558 units

ByQuantisnow·Wall Street's wire, on your screen.
AKTS· Aktis Oncology Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track AKTS (Aktis Oncology Inc.) and more on Quantisnow.